+39 02 610346.1 - info@newron.com

Latest press releases

  • 20Nov
    Newron Completes 5.4 Million USD/CHF Private Placement with U.S. Biotechnology/Healthcare Specialist Fund


  • 13Nov
    Swissmedic approves Xadago® for use in Parkinson’s disease


  • 28Oct
    Newron Pharmaceuticals Announces Planned Pivotal Trial Design for Sarizotan for Patients with Rett Syndrome, a Rare Neurodevelopmental Disease


  • 7Oct
    Meiji announces Initiation of Phase II/III and Long-term Clinical Trials of ME2125 (safinamide) for the Treatment of PD

  • 30Sep
    Xadago® (safinamide) New Drug Application - Late-Cycle Review Meeting Completed with U.S. FDA


  • 15Sep
    Newron reports half-year 2015 results


View All

Newron share price


  • 11Jan
    34th Annual J.P. Morgan Healthcare Conference

    January 11-14, 2016 - the Westin St. Francis, San Francisco, US

  • 9Jan
    2016 East West CEO
    January 9-10, 2016 - Four Seasons Hotel, San Francisco, US
  • 1Dec
    27th annual Piper Jaffray Healthcare Conference

    December 1–2, 2015, The New York Palace, New York, NY, US

View Event Calendar